Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 6, 2009

Baylor College of Medicine Purchases More Sequencers from Applied Biosystems

  • The Baylor College of Medicine Human Genome Sequencing Center (HGSC) is expanding its fleet of next-generation sequencing technology from Applied Biosystems. Additional SOLiD™ Systems will be integrated into the HGSC’s existing base of genomic analysis technologies. With a total of 20 systems, HGSC scientists will use these sequencing platforms to further conduct comprehensive analyses of the genetic changes that characterize cancer, autism, and cardiovascular diseases.

    The HGSC research developments coincide with the NIH’s Gene Sequencing Programs including increased support for determination of genetic changes in each of the three disease areas. With the additional genomic analysis platforms and the increased throughput available from each system, the HGSC expects to at least triple its current sequence production.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »